Bill Aims To Create Approval Process For Biosimilars
A bipartisan group of lawmakers has introduced a bill that would create a regulatory process allowing the U.S. Food and Drug Administration to approve affordable generic versions of biologic drugs....To view the full article, register now.
Already a subscriber? Click here to view full article